RHYTHM PHARMACEUTICALS, INC.
RHYTHM PHARMACEUTICALS, INC. (RYTM) is a publicly traded company in the Unknown sector. Across all available filings, 42 corporate insiders have executed 408 transactions totaling $235.4M, demonstrating a bearish sentiment with -$1.5M in net insider flow. The most recent transaction on Dec 11, 2025 involved a sale of 3,350 shares valued at $371.9K.
RYTM Insider Activity Summary
Who Is Buying RYTM Stock?
No significant insider buying has been recorded for RYTM in the recent period.
Who Is Selling RYTM Stock?
No significant insider selling has been recorded for RYTM in the recent period.
Is RHYTHM PHARMACEUTICALS, INC. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for RYTM is bearish with an Insider Alignment Score of 50/100 and a net flow of -$1.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
RYTM Frequently Asked Questions
Understanding RYTM Insider Activity
Insider trading at RHYTHM PHARMACEUTICALS, INC. (RYTM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 42 insiders are actively trading RYTM stock, having executed 408 transactions in the past 90 days. The most active insider is Todd Foley (Executive), who has made 50 transactions totaling $62.3M.
Related Tools
Track RHYTHM PHARMACEUTICALS, INC. Insider Activity
Get notified when executives and directors at RYTM file new Form 4 transactions